Loading…
Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open‐label, single‐arm, phase 2 study (ISRCTN34303497)
Saved in:
| Published in: | British journal of haematology 2014-03, Vol.164 (6), p.888-890 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 890 |
| container_issue | 6 |
| container_start_page | 888 |
| container_title | British journal of haematology |
| container_volume | 164 |
| creator | Molyneux, Elizabeth Merrick, Blair Khanim, Farhat L. Banda, Kondwani Dunn, Janet A. Iqbal, Gulnaz Bunce, Christopher M. Drayson, Mark T. |
| description | |
| doi_str_mv | 10.1111/bjh.12681 |
| format | article |
| fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmed_primary_24266453</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BJH12681</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2811-1506f9f7f07fb09d5e43f37d8f3c50b981e0b6e50101502624845ab39d2f5ea3</originalsourceid><addsrcrecordid>eNpFkctOFEEUhitGIiOy4AVMbUwwoaGufYkrZyICQU1k9p3T3aeYwupLqnoC7cpH8C14L5-EmuHi2Zzb95_F-Qk54OyYxzipblbHXKQ5f0VmXKY6EVzx12TGGMsSzlS-S96GcMMYl0zzN2RXKJGmSssZuZ_jbzC28jAiha6hLTa-v5sG319jGNH3XZzXOG72tqMegw0jdOMW9uhgCNhQ7BpsbU3na__LjiN1Uzus-hY2km_g4NZ-igLaD9j9-_PXQYXuiAbbXTuMPfj2iA4rCEgFDeO6mejh-dXPxfK7VJJJVWQf35EdAy7g_lPeI8vTL8vFWXL54-v54vNlMoic84RrlprCZIZlpmJFo1FJI7MmN7LWrCpyjqxKUTPOIipSoXKloZJFI4xGkHvk_ePZYV3FT5SDty34qXx-WAQ-PAEQanDGQ1fb8J_LZRGP55E7eeRurcPpZc9ZuXGsjI6VW8fK-cXZtpAPs_mJ_g</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open‐label, single‐arm, phase 2 study (ISRCTN34303497)</title><source>Wiley</source><creator>Molyneux, Elizabeth ; Merrick, Blair ; Khanim, Farhat L. ; Banda, Kondwani ; Dunn, Janet A. ; Iqbal, Gulnaz ; Bunce, Christopher M. ; Drayson, Mark T.</creator><creatorcontrib>Molyneux, Elizabeth ; Merrick, Blair ; Khanim, Farhat L. ; Banda, Kondwani ; Dunn, Janet A. ; Iqbal, Gulnaz ; Bunce, Christopher M. ; Drayson, Mark T.</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.12681</identifier><identifier>PMID: 24266453</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford: Blackwell</publisher><subject>Adolescent ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; bezafibrate ; Bezafibrate - administration & dosage ; Biological and medical sciences ; Burkitt lymphoma ; Burkitt Lymphoma - drug therapy ; Burkitt Lymphoma - epidemiology ; Burkitt Lymphoma - pathology ; Child ; Child, Preschool ; Drug Resistance, Neoplasm ; efficacy ; Endemic Diseases ; Female ; Hematologic and hematopoietic diseases ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Malawi - epidemiology ; Male ; Medical sciences ; medroxyprogesterone ; Medroxyprogesterone Acetate - administration & dosage ; Recurrence ; toxicity ; Tumors</subject><ispartof>British journal of haematology, 2014-03, Vol.164 (6), p.888-890</ispartof><rights>2013 John Wiley & Sons Ltd</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28395018$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24266453$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Molyneux, Elizabeth</creatorcontrib><creatorcontrib>Merrick, Blair</creatorcontrib><creatorcontrib>Khanim, Farhat L.</creatorcontrib><creatorcontrib>Banda, Kondwani</creatorcontrib><creatorcontrib>Dunn, Janet A.</creatorcontrib><creatorcontrib>Iqbal, Gulnaz</creatorcontrib><creatorcontrib>Bunce, Christopher M.</creatorcontrib><creatorcontrib>Drayson, Mark T.</creatorcontrib><title>Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open‐label, single‐arm, phase 2 study (ISRCTN34303497)</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>Adolescent</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>bezafibrate</subject><subject>Bezafibrate - administration & dosage</subject><subject>Biological and medical sciences</subject><subject>Burkitt lymphoma</subject><subject>Burkitt Lymphoma - drug therapy</subject><subject>Burkitt Lymphoma - epidemiology</subject><subject>Burkitt Lymphoma - pathology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Drug Resistance, Neoplasm</subject><subject>efficacy</subject><subject>Endemic Diseases</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Malawi - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>medroxyprogesterone</subject><subject>Medroxyprogesterone Acetate - administration & dosage</subject><subject>Recurrence</subject><subject>toxicity</subject><subject>Tumors</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpFkctOFEEUhitGIiOy4AVMbUwwoaGufYkrZyICQU1k9p3T3aeYwupLqnoC7cpH8C14L5-EmuHi2Zzb95_F-Qk54OyYxzipblbHXKQ5f0VmXKY6EVzx12TGGMsSzlS-S96GcMMYl0zzN2RXKJGmSssZuZ_jbzC28jAiha6hLTa-v5sG319jGNH3XZzXOG72tqMegw0jdOMW9uhgCNhQ7BpsbU3na__LjiN1Uzus-hY2km_g4NZ-igLaD9j9-_PXQYXuiAbbXTuMPfj2iA4rCEgFDeO6mejh-dXPxfK7VJJJVWQf35EdAy7g_lPeI8vTL8vFWXL54-v54vNlMoic84RrlprCZIZlpmJFo1FJI7MmN7LWrCpyjqxKUTPOIipSoXKloZJFI4xGkHvk_ePZYV3FT5SDty34qXx-WAQ-PAEQanDGQ1fb8J_LZRGP55E7eeRurcPpZc9ZuXGsjI6VW8fK-cXZtpAPs_mJ_g</recordid><startdate>201403</startdate><enddate>201403</enddate><creator>Molyneux, Elizabeth</creator><creator>Merrick, Blair</creator><creator>Khanim, Farhat L.</creator><creator>Banda, Kondwani</creator><creator>Dunn, Janet A.</creator><creator>Iqbal, Gulnaz</creator><creator>Bunce, Christopher M.</creator><creator>Drayson, Mark T.</creator><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>201403</creationdate><title>Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open‐label, single‐arm, phase 2 study (ISRCTN34303497)</title><author>Molyneux, Elizabeth ; Merrick, Blair ; Khanim, Farhat L. ; Banda, Kondwani ; Dunn, Janet A. ; Iqbal, Gulnaz ; Bunce, Christopher M. ; Drayson, Mark T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2811-1506f9f7f07fb09d5e43f37d8f3c50b981e0b6e50101502624845ab39d2f5ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>bezafibrate</topic><topic>Bezafibrate - administration & dosage</topic><topic>Biological and medical sciences</topic><topic>Burkitt lymphoma</topic><topic>Burkitt Lymphoma - drug therapy</topic><topic>Burkitt Lymphoma - epidemiology</topic><topic>Burkitt Lymphoma - pathology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Drug Resistance, Neoplasm</topic><topic>efficacy</topic><topic>Endemic Diseases</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Malawi - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>medroxyprogesterone</topic><topic>Medroxyprogesterone Acetate - administration & dosage</topic><topic>Recurrence</topic><topic>toxicity</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Molyneux, Elizabeth</creatorcontrib><creatorcontrib>Merrick, Blair</creatorcontrib><creatorcontrib>Khanim, Farhat L.</creatorcontrib><creatorcontrib>Banda, Kondwani</creatorcontrib><creatorcontrib>Dunn, Janet A.</creatorcontrib><creatorcontrib>Iqbal, Gulnaz</creatorcontrib><creatorcontrib>Bunce, Christopher M.</creatorcontrib><creatorcontrib>Drayson, Mark T.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Molyneux, Elizabeth</au><au>Merrick, Blair</au><au>Khanim, Farhat L.</au><au>Banda, Kondwani</au><au>Dunn, Janet A.</au><au>Iqbal, Gulnaz</au><au>Bunce, Christopher M.</au><au>Drayson, Mark T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open‐label, single‐arm, phase 2 study (ISRCTN34303497)</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2014-03</date><risdate>2014</risdate><volume>164</volume><issue>6</issue><spage>888</spage><epage>890</epage><pages>888-890</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><cop>Oxford</cop><pub>Blackwell</pub><pmid>24266453</pmid><doi>10.1111/bjh.12681</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2014-03, Vol.164 (6), p.888-890 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_pubmed_primary_24266453 |
| source | Wiley |
| subjects | Adolescent Antineoplastic Combined Chemotherapy Protocols - therapeutic use bezafibrate Bezafibrate - administration & dosage Biological and medical sciences Burkitt lymphoma Burkitt Lymphoma - drug therapy Burkitt Lymphoma - epidemiology Burkitt Lymphoma - pathology Child Child, Preschool Drug Resistance, Neoplasm efficacy Endemic Diseases Female Hematologic and hematopoietic diseases Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Malawi - epidemiology Male Medical sciences medroxyprogesterone Medroxyprogesterone Acetate - administration & dosage Recurrence toxicity Tumors |
| title | Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open‐label, single‐arm, phase 2 study (ISRCTN34303497) |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T14%3A22%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bezafibrate%20and%20medroxyprogesterone%20acetate%20in%20resistant%20and%20relapsed%20endemic%20Burkitt%20lymphoma%20in%20Malawi;%20an%20open%E2%80%90label,%20single%E2%80%90arm,%20phase%202%20study%20(ISRCTN34303497)&rft.jtitle=British%20journal%20of%20haematology&rft.au=Molyneux,%20Elizabeth&rft.date=2014-03&rft.volume=164&rft.issue=6&rft.spage=888&rft.epage=890&rft.pages=888-890&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/bjh.12681&rft_dat=%3Cwiley_pubme%3EBJH12681%3C/wiley_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p2811-1506f9f7f07fb09d5e43f37d8f3c50b981e0b6e50101502624845ab39d2f5ea3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/24266453&rfr_iscdi=true |